FDA Questions Reformulated Primatene Asthma Spray Reliability
This article was originally published in The Tan Sheet
Executive Summary
FDA briefing documents for a Feb. 25 advisory committee meeting question whether the design of Armstrong’s new Primatene asthma inhaler device is flawed. The agency’s review of the product’s efficacy and safety are otherwise reassuring.